DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Yang Z, Chen H, Shu M, Zhang Y, Xue L, Lin Y.
DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase
pathway.
Oncology Letters 2019;
17: 2107-2116
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.